Developed in ViraCor’s laboratories, the molecular test accurately detects key genetic mutations associated with antiviral resistance in cytomegalovirus (CMV) in three days or less, the company said. Turnaround time on most CMV antiviral resistance tests is up to two weeks.
Steve Kleiboeker, chief scientific officer of ViraCor, said: “In patients with compromised immune systems, it is critical for doctors to start the right CMV treatment quickly – before serious infection sets in. When we created our CMV antiviral resistance testing service at ViraCor, we were committed to providing the fastest turnaround time possible. We start processing every sample the day we receive it so that doctors can detect antiviral resistant strains of CMV in their patients within a few days, start the right treatment and avoid complications from infection.”